National Penn Investors Trust’s Pfizer PFE Stock Holding History

National Penn Investors Trust’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	$2.14M	Sell	76,005 -5,515	-7%	-$158K	0.25%	90
2015 Q4	$2.5M	Sell	81,520 -316	-0.4%	-$9.94K	0.28%	82
2015 Q3	$2.44M	Sell	81,836 -3,735	-4%	-$120K	0.28%	86
2015 Q2	$2.72M	Sell	85,571 -533	-0.6%	-$17.4K	0.29%	81
2015 Q1	$2.84M	Sell	86,104 -3,230	-4%	-$103K	0.3%	78
2014 Q4	$2.64M	Buy	89,334 +487	+0.5%	+$14K	0.3%	73
2014 Q3	$2.49M	Sell	88,847 -6,849	-7%	-$192K	0.29%	75
2014 Q2	$2.69M	Sell	95,696 -1,107	-1%	-$31.6K	0.32%	65
2014 Q1	$2.95M	Sell	96,803 -6,178	-6%	-$184K	0.35%	59
2013 Q4	$2.99M	Sell	102,981 -658	-0.6%	-$19.1K	0.34%	67
2013 Q3	$2.83M	Buy	103,639 +7,089	+7%	+$193K	0.35%	64
2013 Q2	$2.57M	Buy	+96,550	New	+$2.67M	0.33%	70

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

National Penn Investors Trust's PFE Position: Q1 2016 in Review

National Penn Investors Trust reduced its Pfizer (PFE) stake by 6.8% in Q1 2016, selling an estimated $158K and leaving 76,005 shares worth $2.14M. The position accounts for 0.25% of the portfolio, ranked #90.

National Penn Investors Trust first reported a position in PFE in Q2 2013 and has held it in 12 quarters since. The position peaked at $2.99M in Q4 2013. 1,968 funds tracked by Wall St. Rank hold PFE as of Q1 2016.

National Penn Investors Trust held 76,005 shares of Pfizer worth $2.14M as of Q1 2016.
National Penn Investors Trust sold 5,515 Pfizer shares in Q1 2016, an estimated $158K.
Pfizer made up 0.25% of National Penn Investors Trust's portfolio in Q1 2016, its #90 holding.
National Penn Investors Trust first reported a position in Pfizer in Q2 2013 and has held it in 12 quarters since.
National Penn Investors Trust's Pfizer position peaked at $2.99M in Q4 2013.
1,968 funds tracked by Wall St. Rank held Pfizer as of Q1 2016.

Based on National Penn Investors Trust's 13F filing for Q1 2016, filed 11 May 2016.